Skip to main content

Advertisement

Log in

Androgen synthesis in adrenarche

  • Published:
Reviews in Endocrine and Metabolic Disorders Aims and scope Submit manuscript

Abstract

The enzymes and pathways of steroidogenesis are central to an understanding of adrenarche. The quantitative regulation of steroidogenesis occurs at the first step, the conversion of cholesterol to pregnenolone. Chronic quantitative regulation is principally at the level of transcription of the CYP11A1 gene encoding P450scc, which is the enzymatically rate-limiting step. Acute regulation is mediated by the steroidogenic acute regulatory protein (StAR), which facilitates the rapid influx of cholesterol into mitochondria, where P450scc resides. Qualitative regulation, which determines the type of steroid produced in a cell, is principally at the level of P450c17 (CYP17). In the absence of P450c17 in the zona glomerulosa, C21 deoxy steroids are produced, leading to the mineralocorticoid, aldosterone. In the presence of the 17α-hydroxylase but not the 17,20 lyase activity of P450c17 in the zona fasciculata, C21, 17-hydroxy steroids are produced, leading to the glucocorticoid, cortisol. When both the 17α-hydroxylase and 17,20 lyase activities of P450c17 are present in the zona reticularis, the androgen precursor DHEA is produced. The discrimination between 17α-hydroxylase and 17,20 lyase activities is regulated by two post-translational events, the serine phosphorylation of P450c17 and the allosteric action of cytochrome b5, both of which act to optimize the interaction of P450c17 with its obligatory electron donor, P450 oxidoreductase. In the adrenal zona reticularis, the abundant expression of P450 oxidoreductase and cytochrome b5, and the low expression of 3β-hydroxysteroid dehydrogenase (HSD3B2) result in the production of the large amounts of DHEA that characterize adrenarche.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Ikonen E. Mechanisms for cellular cholesterol transport: defects and human disease. Physiol Rev. 2006;86:1237–61.

    Article  PubMed  CAS  Google Scholar 

  2. Horton JD, Goldstein JL, Brown MS. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest. 2002;109:1125–31.

    PubMed  CAS  Google Scholar 

  3. Waterham HR. Defects of cholesterol biosynthesis. FEBS Lett. 2006;580:5442–9.

    Article  PubMed  CAS  Google Scholar 

  4. Miller WL. Molecular biology of steroid hormone synthesis. Endocr Rev. 1988;9:295–318.

    Article  PubMed  CAS  Google Scholar 

  5. Soccio RE, Breslow JL. Intracellular cholesterol transport. Arterioscler Thromb Vasc Biol. 2004;24:1150–60.

    Article  PubMed  CAS  Google Scholar 

  6. Prinz WA. Non-vesicular sterol transport in cells. Prog Lipid Res. 2007;46:297–314.

    Article  PubMed  CAS  Google Scholar 

  7. Gallegos AM, Atshaves BP, Storey SM, Starodub O, Petrescu AD, Huang H, McIntosh AL, Martin GG, Chao H, Kier AB, Schroeder F. Gene structure, intracellular localization, and functional roles of sterol carrier protein-2. Prog Lipid Res. 2001;40:498–563.

    Article  PubMed  CAS  Google Scholar 

  8. Soccio RE, Breslow JL. StAR-related lipid transfer (START) proteins: mediators of intracellular lipid metabolism. J Biol Chem. 2003;278:22183–6.

    Article  PubMed  CAS  Google Scholar 

  9. Soccio RE, Adams RM, Romanowski MJ, Sehayek E, Burley SK, Breslow JL. The cholesterol-regulated StarD4 gene encodes a StAR-related lipid transfer protein with two closely related homologues, StarD5 and StarD6. Proc Natl Acad Sci USA. 2002;99:6943–8.

    Article  PubMed  CAS  Google Scholar 

  10. Romanowski MJ, Soccio RE, Breslow JL, Burley SK. Crystal structure of the Mus musculus cholesterol-regulated START protein 4 (StarD4) containing a StAR-related lipid transfer domain. Proc Natl Acad Sci USA. 2002;99:6949–54.

    Article  PubMed  CAS  Google Scholar 

  11. Tsujishita Y, Hurley JH. Structure and lipid transport mechanism of a StAR-related domain. Nature Struct Biol. 2000;7:408–14.

    Article  PubMed  CAS  Google Scholar 

  12. Soccio RE, Adams RM, Maxwell KN, Breslow JL. Differential gene regulation of StarD4 and StarD5 cholesterol transfer proteins. J Biol Chem. 2005;280:19410–8.

    Article  PubMed  CAS  Google Scholar 

  13. Ren S, Hylemon PB, Marques D, Hall E, Redford K, Gil G, Pandak WM. Effect of increasing the expression of cholesterol transporters (StAR, MLN64, and SCP-2) on bile acid synthesis. J Lipid Res. 2004;45:2123–31.

    Article  PubMed  CAS  Google Scholar 

  14. Gomes C, Oh S-D, Kim J-W, Chun S-Y, Lee K, Kwon H-B, Soh J. Expression of the putative sterol binding protein Stard6 gene is male germ cell specific. Biol Reprod. 2005;72:651–8.

    Article  PubMed  CAS  Google Scholar 

  15. Bose HS, Whittal RM, Ran Y, Bose M, Baker BY, Miller WL. StAR-like activity and molten globule behavior of StARD6, a male germ-line protein. Biochemistry 2008;47:2277–88.

    Article  PubMed  CAS  Google Scholar 

  16. Sugawara T, Lin D, Holt JA, Martin KO, Javitt NB, Miller WL, Strauss JF III. The structure of the human steroidogenic acute regulatory (StAR) protein gene: StAR stimulates mitochondrial cholesterol 27-hydroxylase activity. Biochemistry 1995;34:12506–12.

    Article  PubMed  CAS  Google Scholar 

  17. Voutilainen R, Tapanainen J, Chung B, Matteson KJ, Miller WL. Hormonal regulation of P450scc (20,22-desmolase) and P450c17 (17α-hydroxylase/17,20-lyase) in cultured human granulosa cells. J Clin Endocrinol Metab. 1986; 63:202–207.

    PubMed  CAS  Google Scholar 

  18. Stocco DM, Clark BJ. Regulation of the acute production of steroids in steroidogenic cells. Endocr Rev. 1996;17:221–4.

    PubMed  CAS  Google Scholar 

  19. Miller WL. StAR search—what we know about how the steroidogenic acute regulatory protein mediates mitochondrial cholesterol import. Mol Endocrinol. 2007;21:589–601.

    Article  PubMed  CAS  Google Scholar 

  20. Simpson ER. Cholesterol side-chain cleavage, cytochrome P450, and the control of steroidogenesis. Mol Cell Endocrinol. 1979;13:213–7.

    Article  PubMed  CAS  Google Scholar 

  21. Pon LA, Hartigan JA, Orme-Johnson NR. Acute ACTH regulation of adrenal corticosteroid biosynthesis: rapid accumulation of a phosphoprotein. J Biol Chem. 1986;261:13309–16.

    PubMed  CAS  Google Scholar 

  22. Epstein LF, Orme-Johnson NR. Regulation of steroid hormone biosynthesis: identification of precursors of a phosphoprotein targeted to the mitochondrion in stimulated rat adrenal cortex cells. J Biol Chem. 1991;266:19739–45.

    PubMed  CAS  Google Scholar 

  23. Stocco DM, Sodeman TC. The 30-kDa mitochondrial proteins induced by hormone stimulation in MA-10 mouse Leydig tumor cells are processed from larger precursors. J Biol Chem. 1991;266:19731–8.

    PubMed  CAS  Google Scholar 

  24. Clark BJ, Wells J, King SR, Stocco DM. The purification, cloning and expression of a novel luteinizing hormone-induced mitochondrial protein in MA-10 mouse Leydig tumor cells. Characterization of the steroidogenic acute regulatory protein (StAR). J Biol Chem. 1994;269:28314–22.

    PubMed  CAS  Google Scholar 

  25. Lin D, Sugawara T, Strauss JF III, Clark BJ, Stocco DM, Saenger P, Rogol A, Miller WL. Role of steroidogenic acute regulatory protein in adrenal and gonadal steroidogenesis. Science 1995;267:1828–31.

    Article  PubMed  CAS  Google Scholar 

  26. Bose HS, Sugawara T, Strauss JF III, Miller WL. The pathophysiology and genetics of congenital lipoid adrenal hyperplasia. New England J Med. 1996;335:1870–8.

    Article  CAS  Google Scholar 

  27. Moore CCD, Hum DW, Miller WL. Identification of positive and negative placental-specific basal elements, a transcriptional repressor, and a cAMP response element in the human gene for P450scc. Mol Endocrinol. 1992;6:2045–58.

    Article  PubMed  CAS  Google Scholar 

  28. Sugawara T, Holt JA, Driscoll D, Strauss JF III, Lin D, Miller WL, Patterson D, Clancy KP, Hart IM, Clark BJ, Stocco DM. Human steroidogenic acute regulatory protein (StAR): Functional activity in COS-1 cells, tissue-specific expression, and mapping of the structural gene to 8p11.2 and an expressed pseudogene to chromosome 13. Proc Natl Acad Sci USA. 1995;92:4778–82.

    Article  PubMed  CAS  Google Scholar 

  29. Bose HS, Lingappa VR, Miller WL. Rapid regulation of steroidogenesis by mitochondrial protein import. Nature 2002;417:87–91.

    Article  PubMed  CAS  Google Scholar 

  30. Bose HS, Whittal RM, Baldwin MA, Miller WL. The active form of the steroidogenic acute regulatory protein, StAR, appears to be a molten globule. Proc Natl Acad Sci USA. 1999;96:7250–5.

    Article  PubMed  CAS  Google Scholar 

  31. Baker BY, Yaworsky DC, Miller WL. A pH-dependent molten globule transition is required for activity of the steroidogenic acute regulatory protein, StAR. J Biol Chem. 2005;280:41753–60.

    Article  PubMed  CAS  Google Scholar 

  32. Papadopoulos V. Peripheral-type benzodiazepine/diazepam binding inhibitor receptor: Biological role in steroidogenic cell function. Endocr Rev. 1993;14:222–40.

    PubMed  CAS  Google Scholar 

  33. Hauet T, Yao ZX, Bose HS, Wall CT, Han Z, Li W, Hales DB, Miller WL, Culty M, Papadopoulos V. Peripheral-type benzodiazepine receptor-mediated action of steroidogenic acute regulatory protein on cholesterol entry into Leydig cell mitochondria. Mol Endocrinol. 2005;19:540–4.

    Article  PubMed  CAS  Google Scholar 

  34. Liu J, Rone MB, Papadopoulos V. Protein–protein interactions mediate mitochondrial cholesterol transport and steroid biosynthesis. J Biol Chem. 2006;281:38879–93.

    Article  PubMed  CAS  Google Scholar 

  35. Bose M, Whittal RM, Miller WL, Bose HS. Steroidogenic activity of StAR requires contact with mitochondrial VDAC1 and PCP. J Biol Chem. 2008;283:8837–45.

    Article  PubMed  CAS  Google Scholar 

  36. Baker BY, Epand RF, Epand RM, Miller WL. Cholesterol binding does not predict activity of the steroidogenic acute regulatory protein, StAR. J Biol Chem. 2007;282:10223–32.

    Article  PubMed  CAS  Google Scholar 

  37. Ventner JC, 186 co-authors. The sequence of the human genome. Science 2001;291:1304–51.

    Article  Google Scholar 

  38. Lander ES, Linton LM, Birren B. Initial sequencing and analysis of the human genome. Nature 2001;409:860.

    Article  PubMed  CAS  Google Scholar 

  39. Guengerich FP. Cytochrome P450: what have we learned and what are the future issues. Drug Metab Rev. 2004;36:159–97.

    Article  PubMed  CAS  Google Scholar 

  40. White PC, Curnow KM, Pascoe L. Disorders of steroid 11β-hydroxylase isozymes. Endocr Rev. 1994;15:421–38.

    PubMed  CAS  Google Scholar 

  41. Miller WL, Morel Y. Molecular genetics of 21-hydroxylase deficiency. Ann Rev Genet. 1989;23:371–93.

    Article  PubMed  CAS  Google Scholar 

  42. Speiser PW, White PC. Congenital adrenal hyperplasia. New England J Med. 2003;349:776–8.

    Article  CAS  Google Scholar 

  43. Simpson ER, Mahendroo MS, Means GD, Kilgore MW, Hinshelwood MM, Graham-Lorence S, Amarneh B, Ito Y, Fisher CR, Michael MD, Mendelson CR, Bulun SE. Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis. Endocr Rev. 1994;15:342–55.

    PubMed  CAS  Google Scholar 

  44. Agarwal AK, Auchus RJ. Cellular redox state regulates hydroxysteroid dehydrogenase activity and intracellular hormone potency. Endocrinology 2005;146:2531–8.

    Article  PubMed  CAS  Google Scholar 

  45. El-Alfy M, Luu-The V, Huang XF, Berger L, Labrie F, Pelletier G. Localization of type 5 17β-hydroxysteroid dehydrogenase, 3β-hydroxysteroid dehydrogenase, and androgen receptor in the human prostate by in situ hybridization and immunocytochemistry. Endocrinology 1999;140:1481–91.

    Article  PubMed  CAS  Google Scholar 

  46. Penning TM, Burczynski ME, Jez JM, Hung CF, Lin HK, Ma H, Moore M, Palackal N, Ratnam K. Human 3α-hydroxysteroid dehydrogenase isoforms (AKR1C1–AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones. Biochem J. 2000;351:67–77.

    Article  PubMed  CAS  Google Scholar 

  47. Chung B, Matteson KJ, Voutilainen R, Mohandas TK, Miller WL. Human cholesterol side-chain cleavage enzyme, P450scc: cDNA cloning, assignment of the gene to chromosome 15, and expression in the placenta. Proc Natl Acad Sci USA. 1986;83:8962–6.

    Article  PubMed  CAS  Google Scholar 

  48. Yang X, Iwamoto K, Wang M, Artwohl J, Mason JI, Pang S. Inherited congenital adrenal hyperplasia in the rabbit is caused by a deletion in the gene encoding cytochrome P450 cholesterol side-chain cleavage enzyme. Endocrinology 1993;132:1977–82.

    Article  PubMed  CAS  Google Scholar 

  49. Hu MC, Hsu NC, El Hadj NB, Pai CI, Chu HP, Wang CKL, Chung BC. Steroid deficiency syndromes in mice with targeted disruption of Cyp11a1. Mol Endocrinol. 2002;16:1943–50.

    Article  PubMed  CAS  Google Scholar 

  50. Miller WL. Regulation of steroidogenesis by electron transfer. Endocrinology 2005;146:2544–50.

    Article  PubMed  CAS  Google Scholar 

  51. Gnanaiah W, Omdahl JL. Isolation and characterization of pig kidney mitochondrial ferredoxin: NADP+oxidoreductase. J Biol Chem. 1986;261:12649–54.

    PubMed  CAS  Google Scholar 

  52. Hanukoglu I, Suh BS, Himmelhoch S, Amsterdam A. Induction and mitochondrial localization of cytochrome P450scc system enzymes in normal and transformed ovarian granulosa cells. J Cell Biol. 1990;111:1373–81.

    Article  PubMed  CAS  Google Scholar 

  53. Solish SB, Picado-Leonard J, Morel Y, Kuhn RW, Mohandas TK, Hanukoglu I, Miller WL. Human adrenodoxin reductase: two mRNAs encoded by a single gene on chromosome 17cen→q25 are expressed in steroidogenic tissues. Proc Natl Acad Sci USA. 1988;85:7104–8.

    Article  PubMed  CAS  Google Scholar 

  54. Picado-Leonard J, Voutilainen R, Kao L, Chung B, Strauss JF III, Miller WL. Human adrenodoxin: cloning of three cDNAs and cycloheximide enhancement in JEG-3 cells. J Biol Chem. 1988;263:3240–4.

    PubMed  CAS  Google Scholar 

  55. Brentano ST, Black SM, Lin D, Miller WL. cAMP post-transcriptionally diminishes the abundance of adrenodoxin reductase mRNA. Proc Natl Acad Sci USA. 1992;89:4099–103.

    Article  PubMed  CAS  Google Scholar 

  56. Thomas JL, Myers RP, Strickler RC. Human placental 3β-hydroxy-5-ene-steroid dehydrogenase and steroid 5→4-ene-isomerase: purification from mitochondria and kinetic profiles, biophysical characterization of the purified mitochondrial and microsomal enzymes. J Steroid Biochem. 1989;33:209–17.

    Article  PubMed  CAS  Google Scholar 

  57. Luu-The V, Lechance Y, Labrie C, Leblanc G, Thomas JL, Strickler RC, Labrie F. Full length cDNA structure and deduced amino acid sequence of human 3β-hydroxy-5-ene steroid dehydrogenase. Mol Endocrinol. 1989;3:1310–2.

    Article  PubMed  CAS  Google Scholar 

  58. Lorence MC, Murry BA, Trant JM, Mason JI. Human 3β-hydroxysteroid dehydrogenase/Δ5→Δ4 isomerase from placenta: expression in nonsteroidogenic cells of a protein that catalyzes the dehydrogenation/isomerization of C21 and C19 steroids. Endocrinology 1990;126:2493–8.

    PubMed  CAS  Google Scholar 

  59. Lee TC, Miller WL, Auchus RJ. Medroxyprogesterone acetate and dexamethasone are competitive inhibitors of different human steroidogenic enzymes. J Clin Endocrinol Metab. 1999;84:2104–2110.

    Article  PubMed  CAS  Google Scholar 

  60. Lachance Y, Luu-The V, Labrie C, Simard J, Dumont M, de Launoit Y, Guerin S, Leblanc G, Labrie F. Characterization of human 3β-hydroxysteroid dehydrogenase/Δ5-Δ4-isomerase gene and its expression in mammalian cells. J Biol Chem. 1990;265:20469–75.

    PubMed  CAS  Google Scholar 

  61. Rhéaume E, Lachance Y, Zhao HL, Breton N, Dumont M, de Launoit Y, Trudel C, Luu-The V, Simard J, Labrie F. Structure and expression of a new complementary DNA encoding the almost exclusive 3β-hydroxysteroid dehydrogenase/Δ5-Δ4-isomerase in human adrenals and gonads. Mol Endocrinol. 1991;5:1147–57.

    Article  PubMed  Google Scholar 

  62. Lorence MC, Corbin CJ, Kamimura N, Mahendroo MS, Mason JI. Structural analysis of the gene encoding human 3β-hydroxysteroid dehydrogenase/Δ5→Δ4 isomerase. Mol Endocrinol. 1990;4:1850–5.

    Article  PubMed  CAS  Google Scholar 

  63. Cherradi N, Rossier MF, Vallotton MB, Timberg R, Friedberg I, Orly J, Wang XJ, Stocco DM, Capponi AM. Submitochondrial distribution of three key steroidogenic proteins (steroidogenic acute regulatory protein and cytochrome P450scc and 3β-hydroxysteroid dehydrogenase isomerase enzymes) upon stimulation by intracellular calcium in adrenal glomerulosa cells. J Biol Chem. 1997;272:7899–907.

    Article  PubMed  CAS  Google Scholar 

  64. Chapman JC, Polanco JR, Min S, Michael SD. Mitochondrial 3 beta-hydroxysteroid dehydrogenase (HSD) is essential for the synthesis of progesterone by corpora lutea: An hypothesis. Reprod Biol Endocrinol. 2005;3:1–13.

    Article  CAS  Google Scholar 

  65. Lin D, Black SM, Nagahama Y, Miller WL. Steroid 17α-hydroxylase and 17,20 lyase activities of P450c17: contributions of serine106 and P450 reductase. Endocrinology 1993;132:2498–506.

    Article  PubMed  CAS  Google Scholar 

  66. Auchus RJ, Lee TC, Miller WL. Cytochrome b5 augments the 17,20 lyase activity of human P450c17 without direct electron transfer. J Biol Chem. 1998;273:3158–65.

    Article  PubMed  CAS  Google Scholar 

  67. Migeon CJ, Keller AE, Lawrence B, Shepard TH II. Dehydroepiandrosterone and androsterone levels in human plasma. Effect of age and sex; day-to-day and diurnal variations. J Clin Endocrinol Metab. 1957;17:1051–62.

    PubMed  CAS  Google Scholar 

  68. Sklar CA, Kaplan SL, Grumbach MM. Evidence for dissociation between adrenarche and gonadarche: studies in patients with idiopathic precocious puberty, gonadal dysgenesis, isolated gonadotropin deficiency, and constitutionally delayed growth and adolescence. J Clin Endocrinol Metab. 1980;51:548–56.

    PubMed  CAS  Google Scholar 

  69. Orentreich N, Brind JL, Rizer RL, Vogelman JH. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab. 1984;59:551–5.

    PubMed  CAS  Google Scholar 

  70. Zachmann M, Vollmin JA, Hamilton W, Prader A. Steroid 17,20 desmolase deficiency: a new cause of male pseudohermaphroditism. Clin Endocrinol. 1972;1:369–85.

    Article  CAS  Google Scholar 

  71. Nakajin S, Hall PF. Microsomal cytochrome P450 from neonatal pig testis. purification and properties of a C21 steroid side-chain cleavage system (17α-hydroxylase-C17,20 lyase). J Biol Chem. 1981;256:3871–6.

    PubMed  CAS  Google Scholar 

  72. Nakajin S, Shinoda M, Haniu M, Shively JE, Hall PF. C21 steroid side-chain cleavage enzyme from porcine adrenal microsomes. Purification and characterization of the 17α-hydroxylase/C17,20 lyase cytochrome P450. J Biol Chem. 1984;259:3971–6.

    PubMed  CAS  Google Scholar 

  73. Zuber MX, Simpson ER, Waterman MR. Expression of bovine 17α-hydroxylase cytochrome P450 cDNA in non-steroidogenic (COS-1) cells. Science 1986;234:1258–61.

    Article  PubMed  CAS  Google Scholar 

  74. Lin D, Harikrishna JA, Moore CCD, Jones KL, Miller WL. Missense mutation Ser106→ Pro causes 17α-hydroxylase deficiency. J Biol Chem. 1991;266:15992–8.

    PubMed  CAS  Google Scholar 

  75. Matteson KJ, Picado-Leonard J, Chung B, Mohandas TK, Miller WL. Assignment of the gene for adrenal P450c17 (17α-hydroxylase/17,20 lyase) to human chromosome 10. J Clin Endocrinol Metab. 1986;63:789–91.

    PubMed  CAS  Google Scholar 

  76. Fan YS, Sasi R, Lee C, Winter JSD, Waterman MR, Lin CC. Localization of the human CYP17 gene (cytochrome P450 17α) to 10q24.3 by fluorescence in situ hybridization and simultaneous chromosome banding. Genomics 1992;14:1110–1.

    Article  PubMed  CAS  Google Scholar 

  77. Picado-Leonard J, Miller WL. Cloning and sequence of the human gene encoding P450c17 (steroid 17α-hydroxylase/17,20 lyase): similarity to the gene for P450c21. DNA 1987;6:439–48.

    PubMed  CAS  Google Scholar 

  78. Wang M, Roberts DL, Paschke R, Shea TM, Masters BSS, Kim JJP. Three-dimensional structure of NADPH-cytochrome P450 reductase: Prototype for FMN- and FAD-containing enzymes. Proc Natl Acad Sci USA. 1997;94:8411–6.

    Article  PubMed  CAS  Google Scholar 

  79. Yamano S, Aoyama T, McBride OW, Hardwick JP, Gelboin HV, Gonzalez FJ. Human NADPH-P450 oxidoreductase: complementary DNA cloning, sequence, vaccinia virus-mediated expression, and localization of the CYPOR gene to chromosome 7. Mol Pharmacol. 1989;35:83–8.

    Google Scholar 

  80. Yanagibashi K, Hall PF. Role of electron transport in the regulation of the lyase activity of C-21 side-chain cleavage P450 from porcine adrenal and testicular microsomes. J Biol Chem. 1986;261:8429–33.

    PubMed  CAS  Google Scholar 

  81. Geller DH, Auchus RJ, Miller WL. P450c17 mutations R347H and R358Q selectively disrupt 17,20-lyase activity by disrupting interactions with P450 oxidoreductase and cytochrome b5. Mol Endocrinol. 1999;13:167–75.

    Article  PubMed  CAS  Google Scholar 

  82. Zhang L, Rodriguez H, Ohno S, Miller WL. Serine phosphorylation of human P450c17 increases 17,20 lyase activity: Implications for adrenarche and for the polycystic ovary syndrome. Proc Natl Acad Sci USA. 1995;92:10619–23.

    Article  PubMed  CAS  Google Scholar 

  83. Pandey AV, Mellon SH, Miller WL. Protein phosphatase 2A and phosphoprotein SET regulate androgen production by P450c17. J Biol Chem. 2003;278:2837–44.

    Article  PubMed  CAS  Google Scholar 

  84. Pandey AV, Miller WL. Regulation of 17,20 lyase activity by cytochrome b5 and by serine phosphorylation of P450c17. J Biol Chem. 2005;280:13265–71.

    Article  PubMed  CAS  Google Scholar 

  85. Tee MK, Dong Q, Miller WL. Pathways leading to the phosphorylation of P450c17 and to the post-translationalo regulation of androgen biosynthesis. Endocrinology 2008;149:2667–77.

    Article  PubMed  CAS  Google Scholar 

  86. Huang N, Pandey AV, Agrawal V, Reardon W, Lapunzina PD, Mowat D, Jabs EW, van Vliet G, Sack J, Flück CE, Miller WL. Diversity and function of mutations in P450 oxidoreductase in patients with Antley–Bixler syndrome and disordered steroidogenesis. Am J Hum Genet. 2005;76:729–49.

    Article  PubMed  CAS  Google Scholar 

  87. Geller DH, Auchus RJ, Mendonça BB, Miller WL. The genetic and functional basis of isolated 17,20 lyase deficiency. Nat Genet. 1997;17:201–5.

    Article  PubMed  CAS  Google Scholar 

  88. Auchus RJ, Miller WL. Molecular modeling of human P450c17 (17α-hydroxylase/17,20-lyase): insights into reaction mechanisms and effects of mutations. Mol Endocrinol. 1999;13:1169–82.

    Article  PubMed  CAS  Google Scholar 

  89. VanDenAkker EL, Koper JW, Boehmer AL, Themmen AP, Verhoef-Post M, Timmerman MA, Otten BJ, Drop SL, DeJong FH. Differential inhibition of 17α-hydroxylase and 17,20 lyase activities by three novel missense CYP17 mutations identified in patients with P450c17 deficiency. J Clin Endocrinol Metab. 2002;87:5714–21.

    Article  CAS  Google Scholar 

  90. Miller WL, Auchus RJ, Geller DH. The regulation of 17,20 lyase activity. Steroids 1997;62:133–42.

    Article  PubMed  CAS  Google Scholar 

  91. Labrie F, Luu-The V, Lin SX, Labrie C, Simard J, Breton R, Bélanger A. The key role of 17β-hydroxysteroid dehydrogenases in sex steroid biology. Steroids 1997;62:148–58.

    Article  PubMed  CAS  Google Scholar 

  92. Moghrabi N, Andersson S. 17β-hydroxysteroid dehydrogenases: physiological roles in health and disease. Trends Endocrinol Metab. 1998;9:265–70.

    Article  PubMed  CAS  Google Scholar 

  93. Penning TM. Molecular endocrinology of hydroxysteroid dehydrogenases. Endocr Rev. 1997;18:281–305.

    Article  PubMed  CAS  Google Scholar 

  94. Peltoketo H, Isomaa V, Mäenlavsta O, Vihko R. Complete amino acid sequence of human placental 17β-hydroxysteroid dehydrogenase deduced from cDNA. FEBS Lett. 1988;239:73–7.

    Article  PubMed  CAS  Google Scholar 

  95. Gast MJ, Sims HF, Murdock GL, Gast PM, Strauss AW. Isolation and sequencing of a complementary deoxyribonucleic acid clone encoding human placental 17 β-estradiol dehydrogenase: identification of the putative cofactor binding site. Am J Obstet Gynecol. 1989;161:1726–31.

    PubMed  CAS  Google Scholar 

  96. Tremblay Y, Ringler GE, Morel Y, Mohandas TK, Labrie F, Strauss JF III, Miller WL. Regulation of the gene for estrogenic 17-ketosteroid reductase lying on chromosome 17cen→q25. J Biol Chem. 1989;264:20458–62.

    PubMed  CAS  Google Scholar 

  97. Ghosh D, Pleuteu VZ, Zhu DW, Wawarzak Z, Duax WL, Plaugborn W, Labrie F, Lin S-X. Structure of human estrogenic 17β-hydroxysteroid dehydrogenase at 2.2 Å resolution. Structure 1995;3:503–13.

    Article  PubMed  CAS  Google Scholar 

  98. Sawicki MW, Erman M, Puranen T, Vihko P, Ghosh D. Structure of the ternary complex of human 17β-hydroxysteroid dehydrogenase type 1 with 3-hydroxyestra-1,3,5,7-tetraen-17-one (equilin) and NADP+. Proc Natl Acad Sci USA. 1999;96:840–5.

    Article  PubMed  CAS  Google Scholar 

  99. Takeyama J, Sasano H, Suzuki T, Iinuma K, Nagura H, Andersson S. 17β-hydroxysteroid dehydrogenase types 1 and 2 in human placenta: an immunohistochemical study with correlation to placental development. J Clin Endocrinol Metab. 1998;83:3710–5.

    Article  PubMed  CAS  Google Scholar 

  100. Geissler WM, Davis DL, Wu L, Bradshaw KD, Patel S, Mendonça BB, Elliston KO, Wilson JD, Russell DW, Andersson S. Male pseudohermaphroiditism caused by mutations of testicular 17β-hydroxysteroid dehydrogenase 3. Nature Genet. 1994;7:34–9.

    Article  PubMed  CAS  Google Scholar 

  101. Andersson S, Geissler WM, Wu L, Davis DL, Grumbach MM, New MI, Schwarz HP, Blethen SL, Mendonca BB, Bloise W, Witchel SF, Cutler GB Jr., Griffin JE, Wilson JD, Russel DW. Molecular genetics and pathophysiology of 17 β-hydroxysteroid dehydrogenase 3 deficiency. J Clin Endocrinol Metab. 1996;81:130–6.

    Article  PubMed  CAS  Google Scholar 

  102. Adamski J, Normand T, Leenders F, Montae D, Begue A, Staehelin D, Jungblut PW, de Launoit Y. Molecular cloning of a novel widely expressed human 80 kDa 17 β-hydroxysteroid dehydrogenase IV. Biochem J. 1995;311:437–43.

    PubMed  CAS  Google Scholar 

  103. Leenders F, Tesdorpf JG, Markus M, Engel T, Seedorf U, Adamski J. Porcine 80-kDa protein reveals intrinsic 17 β-hydroxysteroid dehydrogenase, fatty acyl-CoA-hydratase/dehydrogenase, and sterol transfer activities. J Biol Chem. 1996;271:5438–42.

    Article  PubMed  CAS  Google Scholar 

  104. van Grunsven EG, van Berkel E, Ijlst L, Vreken P, De Klerk JBC, Adamski J, Lemonde H, Clayton PT, Cuebas DA, Wanders RJA. Peroxisomal d-hydroxyacyl-CoA dehydrogenase deficiency: resolution of the enzyme defect and its molecular basis in bifunctional protein deficiency. Proc Natl Acad Sci USA. 1998;95:2128–33.

    Article  PubMed  Google Scholar 

  105. Khanna M, Qin KN, Wang RW, Cheng KC. Substrate specificity, gene structure and tissue-specific distribution of multiple human 3α-hydroxysteroid dehydrogenases. J Biol Chem. 1995;270:20162–8.

    Article  PubMed  CAS  Google Scholar 

  106. Lin HK, Jez JM, Schlegel BP, Peehl DM, Pachter JA, Penning TM. Expression and characterization of recombinant type 2 3 α-hydroxysteroid dehydrogenase (HSD) from human prostate: demonstration of bifunctional 3 α/17β-HSD activity and cellular distribution. Mol Endocrinol. 1997;11:1971–84.

    Article  PubMed  CAS  Google Scholar 

  107. Dufort I, Rheault P, Huang XF, Soucy P, Luu-The V. Characteristics of a highly labile human type 5 17β-hydroxysteroid dehydrogenase. Endocrinology 1999;140:568–74.

    Article  PubMed  CAS  Google Scholar 

  108. Pelletier G, Luu-The V, Tetu B, Labrie F. Immunocytochemical localization of type 5 17β-hydroxysteroid dehydrogenase in human reproductive tissues. J Histochem Cytochem. 1999;47:731–8.

    PubMed  CAS  Google Scholar 

  109. Luu-The V, Dufort I, Pelletier G, Labrie F. Type 5 17β-hydroxysteriod dehydrogenase: its role in the formation of androgens in women. Mol Cell Endocrinol. 2001;171:77–82.

    Article  PubMed  CAS  Google Scholar 

  110. Quinkler M, Sinha B, Tomlinson JW, Bujalska IJ, Stewart PM, Arlt W. Androgen generation in adipose tissue in women with simple obesity—a site-specific role for 17β-hydroxysteroid dehydrogenase type 5. J Endocrinol. 2004;183:331–42.

    Article  PubMed  CAS  Google Scholar 

  111. Qiu W, Zhou M, Mazumdar M, Azzi A, Ghanmi D, Luu-The V, Labrie F, Lin SX. Structure-based inhibitor design for an enzyme that binds different steroids. J Biol Chem. 2007;282:8368–79.

    Article  PubMed  CAS  Google Scholar 

  112. Qiu W, Zhou M, Labrie F, Lin SX. Crystal structures of the multispecific 17β-hydroxysteroid dehydrogenase type 5: critical androgen regulation in human peripheral tissues. Mol Endocrinol. 2004;18:1798–807.

    Article  PubMed  CAS  Google Scholar 

  113. Falany CN. Enzymology of human cystolic sulfotransferases. FASEB J. 1997;11:206–16.

    PubMed  CAS  Google Scholar 

  114. Stroh CA. Sulfonation and molecular action. Endocr Rev. 2002;23:703–32.

    Article  CAS  Google Scholar 

  115. Tong MH, Jiang H, Liu P, Lawson JA, Brass LF, Song W-C. Spontaneous fetal loss caused by placental thrombosis in estrogen sulfutransferase-deficient mice. Nature Medicine. 2005;11:153–9.

    Article  PubMed  CAS  Google Scholar 

  116. Nowell S, Falany CN. Pharmacogenetics of human cytosolic sulfotransferases. Oncogene 2006;25:1673–8.

    Article  PubMed  CAS  Google Scholar 

  117. Yen PH, Allen E, Marsh B, Mohandas T, Shapiro LJ. Cloning and expression of steroid sulfatase cDNA and the frequent occurrence of deletions: implications for X–Y interchange. Cell 1987;49:443–54.

    Article  PubMed  CAS  Google Scholar 

  118. Ballabio A, Shapiro LJ. Steroid Sulfatase deficiency and X-linked icthiosis. In: Schriver CR, Beaduet AL, Sly WS, Valle D, editors. The metabolic and molecular basis of inherited disease. New York: Mc-Graw-Hill; 1995. p. 2999–3022.

    Google Scholar 

  119. Compagnone NA, Salido E, Shapiro LJ, Mellon SH. Expression of steroid sulfatase during embryogenesis. Endocrinology 1997;138:4768–73.

    Article  PubMed  CAS  Google Scholar 

  120. Compagnone NA, Mellon SH. Dehydroepiandrosterone: A potential signalling molecule for neocortical organization during development. Proc Natl Acad Sci USA. 1998;95:4678–83.

    Article  PubMed  CAS  Google Scholar 

  121. Grumbach MM, Auchus RJ. Estrogen: consequences and implications of human mutations in synthesis and action. J Clin Endocrinol Metab. 1999;84:4677–94.

    Article  PubMed  CAS  Google Scholar 

  122. Ito Y, Fisher CR, Conte FA, Grumbach MM, Simpson ER. Molecular basis of aromatase deficiency in an adult female with sexual infantilism and polycystic ovaries. Proc Natl Acad Sci USA. 1993;90:11673–7.

    Article  PubMed  CAS  Google Scholar 

  123. Conte FA, Grumbach MM, Ito Y, Fisher CR, Simpson ER. A syndrome of female pseudohermaphrodism, hypergonadotropic hypogonadism, and multicystic ovaries associated with missense mutations in the gene encoding aromatase (P450arom). J Clin Endocrinol Metab. 1994;78:1287–92.

    Article  PubMed  CAS  Google Scholar 

  124. Staels B, Hum DW, Miller WL. Regulation of steroidogenesis in NCI-H295 cells: A cellular model of the human fetal adrenal. Mol Endocrinol. 1993;7:423–33.

    Article  PubMed  CAS  Google Scholar 

  125. Andersson S, Russell DW. Structural and biochemical properties of cloned and expressed human rat steroid 5α-reductases. Proc Natl Acad Sci USA. 1990;87:3640–4.

    Article  PubMed  CAS  Google Scholar 

  126. Jenkins EP, Hsieh CL, Milatovich A, Normington K, Berman DM, Francke U, Russell DW. Characterization and chromosomal mapping of a human steroid 5α-reductase gene and pseudogene and mapping of the mouse homologue. Genomics 1991;11:1102–12.

    Article  PubMed  CAS  Google Scholar 

  127. Thigpen AE, Silver RI, Guileyardo JM, Casey ML, McConnell JD, Russell DW. Tissue distribution and ontogeny of steroid 5α-reductase isozyme expression. J Clin Invest. 1993;92:903–10.

    Article  PubMed  CAS  Google Scholar 

  128. Andersson S, Berman DM, Jenkins EP, Russell DW. Deletion of a steroid 5α-reductase 2 gene in male pseudohermaphroditism. Nature 1991;354:159.

    Article  PubMed  CAS  Google Scholar 

  129. Goto M, Hanley KP, Marcos J, Wood PJ, Wright S, Postle AD, Cameron IT, Mason JI, Wilson DI, Hanley NA. In humans, early cortisol biosynthesis provides a mechanism to safeguard female sexual development. J Clin Invest. 2006;116:953–60.

    Article  PubMed  CAS  Google Scholar 

  130. Voutilainen R, Ilvesmaki V, Miettinen PJ. Low expression of 3β-hydroxy-5-ene steroid dehydrogenase gene in human fetal adrenals in vivo; adrenocorticotropin and protein kinase C-dependent regulation in adrenocortical cultures. J Clin Endocrinol Metab. 1991;72:761–7.

    PubMed  CAS  Google Scholar 

  131. Fujieda K, Faiman C, Feyes FI, Winter JSD. The control of steroidogenesis by human fetal adrenal cells in tissue culture: IV. The effects of exposure to placental steroids. J Clin Endocrinol Metab. 1982;54:89–94.

    PubMed  CAS  Google Scholar 

  132. Pasqualini JR, Nguyen BL, Uhrich F, Wiqvist N, Diczfalvay E. Cortisol and cortisone metabolism in the human fetoplacental unit at midgestation. J Steroid Biochem. 1970;1:209–19.

    Article  CAS  Google Scholar 

  133. Kari MA, Raivio KO, Stenman U-H, Voutilainen R. Serum cortisol, dehydroepiandrosterone sulfate, and sterol-binding globulins in preterm neonates: effects of gestational age and dexamethasone therapy. Pediatr Res. 1996;40:319–24.

    Article  PubMed  CAS  Google Scholar 

  134. DiBlasio AM, Voutilainen R, Jaffe RB, Miller WL. Hormonal regulation of mRNAs for P450scc (cholesterol side-chain cleavage enzyme) and P450c17 (17α-hydroxylase/17,20 lyase) in cultured human fetal adrenal cells. J Clin Endocrinol Metab. 1987;65:170–5.

    CAS  Google Scholar 

  135. Voutilainen R, Miller WL. Coordinate tropic hormone regulation of mRNAs for insulin-like growth factor II and the cholesterol side-chain cleavage enzyme, P450scc, in human steroidogenic tissues. Proc Natl Acad Sci USA. 1987;84:1590–4.

    Article  PubMed  CAS  Google Scholar 

  136. New MI, Wilson RC. Steroid disorders in children: congenital adrenal hyperplasia and apparent mineralocorticoid excess. Proc Natl Acad Sci USA. 1999;96:12790–7.

    Article  PubMed  CAS  Google Scholar 

  137. Arlt W, Callies F, van Vlijmen JC, Koehler I, Reincke M, Bidlingmaier M, Huebler D, Oettel M, Ernst M, Schulte HM, Allolio B. Dehydroepiandrosterone replacement in women with adrenal insufficiency. New England J Med. 1999;341:1013–20.

    Article  CAS  Google Scholar 

  138. Gurnell EM, Hunt PJ, Curran SE, Conway CL, Pullenayegum EM, Huppert FA, Compston JE, Herbert J, Chatterjee VKK. Long-term DHEA replacement in primary adrenal insufficiency: a randomized, controlled trial. J Clin Endocrinol Metab. 2008;93:400–9.

    Article  PubMed  CAS  Google Scholar 

  139. Løvås K, Gebre-Medhin G, Trovik TS, Fougner KJ, Uhlving S, Nedrebø BG, Myking OL, Kämpe O, Husebye ES. Replacement of dehydroepiandrosterone in adrenal failure: no benefit for subjective health status and sexuality in a 9-month, randomized, parallel group clinical trial. J Clin Endocrinol Metab. 2003;88:1112–8.

    Article  PubMed  CAS  Google Scholar 

  140. Wierman ME, Basson R, Davis SR, Khosla S, Miller KL, Rosner W, Santoro N. Androgen therapy in women: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2006;91:3697–710.

    Article  PubMed  CAS  Google Scholar 

  141. Mellon SH, Shively JE, Miller WL. Human proopiomelanocortin (79–96), a proposed androgen stimulatory hormone, does not affect steroidogenesis in cultured human fetal adrenal cells. J Clin Endocrinol Metab. 1991;72:19–22.

    PubMed  CAS  Google Scholar 

  142. Penhoat A, Sanchez P, Jaillard C, Langlois D, Begeot M, Saez JM. Human proopiomelanocortin (79–96), a proposed cortical androgen stimulating hormone, does not affect steroidogenesis in cultured human adult adrenal cells. J Clin Endocrinol Metab. 1991;72:23–6.

    Article  PubMed  CAS  Google Scholar 

  143. Arlt W, Martens JWM, Song M, Wang JT, Auchus RJ, Miller WL. Molecular evolution of adrenarche: Structural and functional analysis of P450c17 from four primate species. Endocrinology 2002;143:4665–72.

    Article  PubMed  CAS  Google Scholar 

  144. Endoh A, Kristiansen SB, Casson PR, Buster JE, Hornsby PJ. The zona reticularis is the site of biosynthesis of dehydroepiandrosterone and dehydroepiandrosterone sulfate in the adult human adrenal cortex resulting from its low expression of 3β-hydroxysteroid dehydrogenase. J Clin Endocrinol Metab. 1996;81:3558–65.

    Article  PubMed  CAS  Google Scholar 

  145. Gell JS, Carr BR, Sasano H, Atkins B, Margraf L, Mason JI, Rainey WE. Adrenarche results from development of a 3β-hydroxysteroid dehydrogenase-deficient adrenal reticularis. J Clin Endocrinol Metab. 1998;83:3695–701.

    Article  PubMed  CAS  Google Scholar 

  146. Dardis A, Saraco N, Rivarola MA, Belgorosky A. Decrease in the expression of the 3β-hydroxysteroid dehydrogenase gene in human adrenal tissue during prepuberty and early puberty: Implications for the mechanism of adrenarche. Pediatr Res. 1999;45:384–8.

    Article  PubMed  CAS  Google Scholar 

  147. Yanase T, Sasano H, Yubisui T, Sakai Y, Takayanagi R, Nawata H. Immunohistochemical study of cytochrome b5 in human adrenal gland and in adrenocortical adenomas from patients with Cushing’s syndrome. Endocr J. 1998;45:89–95.

    Article  PubMed  CAS  Google Scholar 

  148. Mapes S, Corbin CJ, Tarantal A, Conley A. The primate adrenal zona reticularis is defined by expression of cytochrome b5, 17α-hydroxylase/17,20-lyase cytochrome P450 (P450c17) and NADPH-cytochrome P450 reductase (reductase) but not 3β-hydroxysteroid dehydrogenase/Δ5–4 isomerase (3β-HSD). J Clin Endocrinol Metab. 1999;84:3382–5.

    Article  PubMed  CAS  Google Scholar 

  149. Palmert MR, Hayden DL, Mansfield MJ, Crigler JR Jr, Crowley WF Jr, Chandler DW, Boepple PA. The longitudinal study of adrenal maturation during gonadal suppression: evidence that adrenarche is a gradual process. J Clin Endocrinol Metab. 2001;86:4536–42.

    Article  PubMed  CAS  Google Scholar 

  150. Lin CJ, Martens JWM, Miller WL. NF-1c, Sp1 and Sp3 are essential for transcription of the human gene for P450c17 (steroid 17α-hydroxylase/17,20 lyase in human adrenal NCI-H295A cells. Mol Endocrinol. 2001;15:1277–93.

    Article  PubMed  CAS  Google Scholar 

  151. Flück CE, Miller WL. GATA-4 and GATA-6 modulate tissue-specific transcription of the human gene for P450c17 by direct interaction with Sp1. Mol Endocrinol. 2004;18:1144–57.

    Article  PubMed  CAS  Google Scholar 

  152. Huang N, Dardis A, Miller WL. Regulation of cytochrome b5 gene expression by Sp3, GATA-6, and NF-1 in human adrenal NCI-H295A cells. Mol Endocrinol. 2005;19:2020–34.

    Article  PubMed  CAS  Google Scholar 

  153. Ibañez L, Potau N, Virdis R, Zampolli M, Terzi C, Gussinyé M, Carrascosa A, Vicens-Calvet E. Postpubertal outcome in girls diagnosed of premature pubarche during childhood: Increased frequency of functional ovarian hyperandrogenism. J Clin Endocrinol Metab. 1993;76:1599–603.

    Article  PubMed  Google Scholar 

  154. Oppenheimer E, Linder B, DiMartino-Nardi J. Decreased insulin sensitivity in prepubertal girls with premature adrenarche and acanthosis nigricans. J Clin Endocrinol Metab. 1995;80:614–8.

    Article  PubMed  CAS  Google Scholar 

  155. Ibañez L, Potau N, Zampolli M, Prat N, Virdis R, Vicnes-Calvert E, Carrascosa A. Hyperinsulinemia in postpubertal girls with a history of premature pubarche and functional ovarian hyperandrogenism. J Clin Endocrinol Metab. 1996;81:1237–43.

    Article  PubMed  Google Scholar 

  156. Ibañez L, Potau N, Marcos MV, de Zegher F. Exaggerated adrenarche and hyperinsulinism in adolescent girls born small for gestational age. J Clin Endocrinol Metab. 1998;84:4739–41.

    Article  Google Scholar 

  157. Nair KS, Rizza RA, O’Brien P, Dhatariya K, Short KR, Nehra A, Vittone JL, Klee GG, Basu A, Basu R, Cobelli C, Toffolo G, Man CD, Tindall DJ, Melton LJ III, Smith GE, Khosla S, Jensen MD. DHEA in elderly women and DHEA or testosterone in eldery men. New England J Med. 2006;355:1647–59.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Walter L. Miller.

Additional information

Supported by National Institutes of Health Grants DK37922, HD41958 and GM73020.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Miller, W.L. Androgen synthesis in adrenarche. Rev Endocr Metab Disord 10, 3–17 (2009). https://doi.org/10.1007/s11154-008-9102-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11154-008-9102-4

Keywords

Navigation